Immunosteroid as a regulator for Th1/Th2 balance: Its possible role in autoimmune diseases

References

• Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17: 138–146
   PubMedGoogle Scholar
• Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245–252
   PubMed Web of Science ®Google Scholar
• Chamoto K, Takeshima T, Kosaka A, Tsuji T, Matsuzaki J, Togashi Y, et al. NKT cells act as regulatory cells rather than killer cells during activation of NK cell-mediated cytotoxicity by α-galactosylceramide in vivo. Immunol Lett 2004; 95: 5–11
   PubMed Web of Science ®Google Scholar
• Nishimura T, Ohta A. A critical role for antigen-specific Th1 cells in acute liver injury in mice. J Immunol 1999; 162: 6503–6509
   PubMed Web of Science ®Google Scholar
• Nishimura T, Sadata A, Yahagi C, Santa K, Otsuki K, Watanabe K, et al. The therapeutic effect of interleukin-12 or its antagonist in transplantation immunity. Ann NY Acad Sci 1996; 795: 371–374
   PubMed Web of Science ®Google Scholar
• Liblau RS, Singer SM, McDevitt HO. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995; 16: 34–38
   PubMedGoogle Scholar
• O'Garra A, Steinman L, Gijbels K. CD4+ T-cell subsets in autoimmunity. Curr Opin Immunol 1997; 9: 872–883
   PubMed Web of Science ®Google Scholar
• Robinson DS, Hamid O, Ying S, Tsicopoulos A, Barkans J, Bentley AM, et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic athma. N Engl J Med 1992; 326: 298–304
   PubMed Web of Science ®Google Scholar
• Funauchi M, Ikoma S, Enomoto H, Horiuchi A. Decreased Th1-like and increased Th2-like cells in systemic lupus erythematosus. Scand J Rheumatol 1998; 27: 219–224
   PubMed Web of Science ®Google Scholar
• Whitacre CC. Sex differences in autoimmune disease. Nat Immunol 2001; 2: 777–780
   PubMed Web of Science ®Google Scholar
• Amadori A, Zamarchi R, De Silvestro G, Forza G, Cavatton G, Danieli GA, et al. Genetic control of the CD4/CD8 T-cell ratio in humans. Nat Med 1995; 1: 1279–1283
   PubMed Web of Science ®Google Scholar
• Raghupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunol. Today 1977; 18: 478–482
   Google Scholar
• Dealtry GB, O'Farrell MK, Fernandez N. The Th2 cytokine environment of the placenta. Int Arch Allergy Immunol 2000; 123: 107–119
   PubMed Web of Science ®Google Scholar
• Faas M, Bouman A, Moes H, Heineman MJ, de Leij L, Schuiling G. The immune response during the luteal phase of the ovarian cycle: A Th2-type response?. Fertil Steril 2000; 74: 1008–1013
   PubMed Web of Science ®Google Scholar
• Krishnan L, Guilbert LJ, Russell AS, Wegmann TG, Mosmann TG, Belosevic M. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFNγ responses and increased production of T helper 2 cytokines. J Immunol 1996; 156: 653–662
   PubMed Web of Science ®Google Scholar
• Chaouat G, Meliani AA, Martal J, Raghupathy R, Elliot J, Mosmann T, et al. IL-10 prevents naturally occurring fetal loss in the CBA × DBA/2 mating combination, and local defect in IL-10 production in this abortion-prone combination is corrected by in vivo injection of IFNγ. J Immunol 1995; 154: 4261–4268
   PubMed Web of Science ®Google Scholar
• Wilder RL. Hormone, pregnancy, and autoimmune diseases. Ann NY Acad Sci 1998; 840: 45–50
   PubMed Web of Science ®Google Scholar
• Choi BC, Polgar K, Xiao L, Hill JA. Progesterone inhibits in vitro embryotoxic Th1 cytokine production to trophoblast in women with recurrent pregnancy loss. Hum Reprod 2000; 15: 46–59
   PubMed Web of Science ®Google Scholar
• Piccinni M, Scaletti C, Maggi E, Romagnani S. Role of hormone-controlled Th1- and Th2-type cytokines in successful pregnancy. J Neuroimmunol 2000; 109: 30–33
   PubMed Web of Science ®Google Scholar
• Lechner O, Wiegers GJ, Oliveira-dos Santos AJ, Dietrich H, Recheis H, Waterman M, et al. Glucocorticoid production in the immune thymus. Eur J Immunol 2000; 30: 337–346
   PubMed Web of Science ®Google Scholar
• Pazirandeh A, Xue Y, Rafter I, Sjovall J, Jondal M, Okret S. Paracrince glucocorticoid activity produced by mouse thymic epithelial cells. FASEB J 1999; 13: 893–901
   PubMed Web of Science ®Google Scholar
• Weinstein Y. 20α-hydroxysteroid dehydrogenase: A T lymphocyte-associated enzyme. J Immunol 1977; 119: 1223–1229
   PubMed Web of Science ®Google Scholar
• Ihle JN, Pepersack L, Rebar L. Regulation of T cell differentiation: In vitro induction of 20α-hydroxysteroid dehydrogenase in splenic lymphocytes from athymic mice by unique lymhokine. J Immunol 1981; 126: 2184–2189
   PubMed Web of Science ®Google Scholar
• Hirabayashi K, Suzuki M, Takahashi M, Nishimura M. Expression of ovarian 20α-hydroxysteroid dehydrogenase in rat thymus. Endocr J 2001; 48: 557–563
   PubMed Web of Science ®Google Scholar
• Hapel AJ, Osbone JM, Fung C, Young IG, Allan W, Hume DA. Expression of 20-α-hydroxysteroid dehydrogenase in mouse macrophages, hemopoietic cells, and cell lines and its induction by colony-stimulating factors. J Immunol 1985; 134: 2492–2497
   PubMed Web of Science ®Google Scholar
• Piccinni M, Giudizi M, Biagiotti R, Beloni L, Giannarini L, Sampognaro S, et al. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol 1995; 155: 128–133
   PubMed Web of Science ®Google Scholar
• Miyaura H, Iwata M. Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids. J Immunol 2002; 168: 1087–1094
   PubMed Web of Science ®Google Scholar
• Moro MH, Bjornsson J, Marietta EV, Hofmeister EK, Germer JJ, Bruinsma E, et al. Gestational attenuation of Lyme arthritis is mediated by progesterone and IL-4. J Immunol 2001; 166: 7404–7409
   PubMed Web of Science ®Google Scholar
• Szekeres-Bartho J, Barakonyi A, Par G, Polgar B, Palkovics T, Szereday L. Progesterone as an immunomodulatory molecules. Int Tiimupharmacol 2001; 1: 1037–1048
   PubMed Web of Science ®Google Scholar
• Piccinni MP, Beloni L, Livi C, Maggi E, Scarselli G, Romagnani S. Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nat Med 1998; 4: 1020–1024
   PubMed Web of Science ®Google Scholar
• Yahata T, Yahata C, Ohta A, Sekimoto M, Kitamura H, Iwakabe K, et al. Interleukin-4-dependent induction of preproenkephalin in antigen-specific T helper-type 2 (Th2) cells. J Neuroimmunol 2000; 105: 103–108
   PubMed Web of Science ®Google Scholar
• Traver D, Akashi K, Manz M, Merad M, Miyamoto T, Engleman EG, et al. Development of CD8α-positive dendritic cells from a common myeloid progenitor. Science 2000; 290: 2152–2154
   PubMed Web of Science ®Google Scholar
• Sato M, Iwakabe K, Ohta A, Sekimoto M, Nakui M, Koda T, et al. Functional heterogeneity among bone marrow-derived dendritic cells conditioned by Th1- and Th2-biasing cytokines for the generation of allogeneic cytotoxic T lymphocytes. Int Immunol 2000; 12: 335–342
   PubMed Web of Science ®Google Scholar
• Sato M, Chamoto K, Nishimura T. A novel tumor-vaccine cell therapy using bone marrow-derived dendritic cell type 1 and antigen-specific Th1 cells. Int Immunol 2003; 15: 837–843
   PubMed Web of Science ®Google Scholar
• Lemire JM. Immunomodulatory actions of 1,25-dihydroxyvitamin D3. J Steroid Biochem Mol Biol 1995; 53: 599–602
   PubMed Web of Science ®Google Scholar
• Liu M, Lee MH, Cohen M, Bommakanti M, Freedman LP. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 1996; 10: 142–153
   PubMed Web of Science ®Google Scholar
• Morrison NA, Shine J, Fragonas JC, Verkest V, McMenemy ML, Eisman JA. 1,25-Dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcinin gene. Science 1989; 246: 1158–1161
   PubMed Web of Science ®Google Scholar
• Takeyama K, Kitanaka S, Sato T, Kobori M, Yanagisawa J, Kato S. 25-Hydroxyvitamin D3 1α-hydroxylase and vitamin D synthesis. Science 1997; 277: 1827–1830
   PubMed Web of Science ®Google Scholar
• D'Ambrosio D, Cippitelli M, Cocciolo MG, Mazzeo D, Di Lucia P, Lang R, et al. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. J Clin Invest 1998; 101: 252–262
   PubMed Web of Science ®Google Scholar
• Cippitelli M, Santoni A. Vitamin D3: A transcriptional modulator of the interferon-γ gene. Eur J Immunol 1998; 28: 3017–3030
   PubMed Web of Science ®Google Scholar
• Alroy I, Towers TL, Freedman LP. Transcriptional repression of the interleukin-2 gene by vitamin D3: Direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol 1995; 15: 5789–5799
   PubMed Web of Science ®Google Scholar
• Lemire JM, Ince A, Takashima M. 1,25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL/l mice. Autoimmunity 1992; 12: 143–148
   PubMed Web of Science ®Google Scholar
• Mathieu C, Waer M, Laureys J, Rutgeerts O, Bouillon R. Prevention of autoimmune diabetes in NOD mice by 1,25-dihydroxyvitamin D3. Diavetologia 1994; 37: 552–558
   PubMed Web of Science ®Google Scholar
• Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF, et al. In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 2002; 195: 603–616
   PubMed Web of Science ®Google Scholar
• Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HFJ, O'Garra A. 1α,25-Dihydroxyvitamin D3 has a direct effect on naïve CD4+ T cells to enhance the development of Th2 cells. J Immunol 2001; 167: 4974–4980
   PubMed Web of Science ®Google Scholar
• Adams JS. Vitamin D metabolite-mediated hypercalcemia. Endocrinol Metab Clin North Am 1989; 18: 765–778
   PubMed Web of Science ®Google Scholar
• Yokomura K, Suda T, Sasaki S, Inui N, Chida K, Nakamura H. Increased expression of the 25-hydroxyvitamin D3-1α-hydroxylase gene in alveolar macrophages of patients with lung cancer. J Clin Endocrinol Metab 2003; 88: 5704–5709
   PubMed Web of Science ®Google Scholar
• Fritsche J, Mondal K, Ehrnsperger A, Andreesen R, Kreutz M. Regulation of 25-hydroxyvitamin D3-1α-hydroxylase and production of 1α,25-dihydroxyvitamin D3 by human dendritic cells. Blood 2003; 102: 3314–3316
   PubMed Web of Science ®Google Scholar
• Kreutz M, Andreesen R, Krause SW, Szabo A, Ritz E, Reichel H. 1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. Blood 1993; 82: 1300–1307
   PubMed Web of Science ®Google Scholar
• Hewison M, Freeman L, Hughes SV, Evans KN, Bland R, Eliopoulos AG, et al. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol 2003; 170: 5382–5390
   PubMed Web of Science ®Google Scholar